用直接方法估计的儿童血红蛋白参考间隔和曲线:系统性审查和元分析
Vid Bijelić1,2, Marijana Bijelić1, Josh Larock3
1School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
International journal of laboratory hematology
|May 3, 2025
概括
这项研究综合了儿科血红蛋白参考间隔 (RIs) 和参考曲线 (RCs) 的证据,发现了显著的异质性. 需要更严格的全球估计来准确地定义儿童,特别是最年轻的贫血.
科学领域:
- 临床化学 临床化学
- 儿科血液学 儿科血液学
- 公共卫生 公共卫生
背景情况:
- 血红蛋白检测对于评估儿童健康至关重要.
- 实验室使用参考间隔 (RIs) 和参考曲线 (RCs) 来解释儿科血红蛋白结果.
- 现有的RI/RC显示出相当大的差异,影响贫血的诊断.
研究的目的:
- 系统地审查和综合有关儿科血红蛋白RI/RCs的证据.
- 调查现有的儿科血红蛋白RI/RCs中异质性的来源.
- 将结果与世界卫生组织 (WHO) 贫血门进行比较.
主要方法:
- 对儿科血红蛋白RI/RCs的研究进行系统审查 (PROSPERO:CRD42023399802).
- 在EMBASE,MEDLINE,SCOPUS和Cochrane图书馆搜索到2023年7月31日.
- 包括遵守CLSI指南并报告置信区间的研究;不包括不健康的儿童和带血RI.
主要成果:
- 分析了来自25个国家的48项研究 (123,498名参与者).
- 0-3个月的统计估计是不可能的;对于年长的儿童,RI通常随着年龄的增长而增加.
- 发现了显著的异质性,来源包括年龄,性别,分析器类型和国家;许多RI不同于世卫组织的值.
结论:
- 儿科血红蛋白RI/RC的实质性异质性需要更强大的全球估计.
- 需要改进RI/RC,以与世卫组织的贫血门保持一致,以便进行一致的诊断.
- 建议对婴儿的RI进行进一步的研究,并使用百分位曲线.
相关概念视频
Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Distribution
554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271


